Vascular growth factors play critical roles in kidney glomeruli

Clinical Science

Volumn 129, Issue 12, 2015, Pages 1225-1236

  Gnudi, Luigi ^a   Benedetti, Sara ^b   Woolf, Adrian S ^c   Long, David A ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiopoietins; Endothelial cells; Glomerulus; Permeability; Podocytes; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOPOIETIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

DIABETIC NEPHROPATHY; GENE EXPRESSION; GLOMERULOPATHY; GLOMERULUS; HUMAN; KIDNEY EPITHELIUM; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENDOTHELIUM CELL; EPITHELIUM CELL; GENETICS; GLOMERULUS FILTRATION RATE; KIDNEY DISEASES; METABOLISM; PATHOPHYSIOLOGY; VASCULARIZATION;

ANGIOPOIETINS; ANIMALS; DIABETIC NEPHROPATHIES; ENDOTHELIAL CELLS; EPITHELIAL CELLS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 84952039692     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150403     Document Type: Review

References (104)

1. Tryggvason, K., Pikkarainen, T. and Patrakka, J. (2006) Nck links nephrin to actin in kidney podocytes. Cell 125, 221-224
2. Greka, A. and Mundel, P. (2012) Cell biology and pathology of podocytes. Ann. Rev. Physiol. 74, 299-323
3. Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.C., Niaudet, P. and Antignac, C. (2000) NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat. Genet. 24, 349-354
4. Kestila, M., Lenkkeri, U., Mannikko, M., Lamerdin, J., McCready, P., Putaala, H., Ruotsalainen, V., Morita, T., Nissinen, M., Herva, R. et al. (1998) Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol. Cell 1, 575-582
5. Ichimura, K., Stan, R.V., Kurihara, H. and Sakai, T. (2008) Glomerular endothelial cells form diaphragms during development and pathologic conditions. J. Am. Soc. Nephrol. 19, 1463-1471
6. Brunskill, E.W. and Potter, S.S. (2010) Gene expression programs of mouse endothelial cells in kidney development and disease. PLoS One 5, e12034
7. Haraldsson, B., Nystrom, J. and Deen, W.M. (2008) Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 88, 451-487
8. Salmon, A.H., Ferguson, J.K., Burford, J.L., Gevorgyan, H., Nakano, D., Harper, S.J., Bates, D.O. and Peti-Peterdi, J. (2012) Loss of the endothelial glycocalyx links albuminuria and vascular dysfunction. J. Am. Soc. Nephrol. 23, 1339-1350
9. Domigan, C.K., Ziyad, S. and Iruela-Arispe, M.L. (2015) Canonical and noncanonical vascular endothelial growth factor pathways: new developments in biology and signal transduction. Arterioscler. Thromb. Vasc. Biol. 35, 30-39
10. Harper, S.J. and Bates, D.O. (2008) VEGF-A splicing: the key to anti-angiogenic therapeutics? Nat. Rev. Cancer 8, 880-887
11. Simon, M., Grone, H.J., Johren, O., Kullmer, J., Plate, K.H., Risau, W. and Fuchs, E. (1995) Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268 (2 Pt 2), F240-F250
12. Kretzler, M., Schroppel, B., Merkle, M., Huber, S., Mundel, P., Horster, M. and Schlondorff, D. (1998) Detection of multiple vascular endothelial growth factor splice isoforms in single glomerular podocytes. Kidney Int. Suppl. 67, S159-S161
13. Maharaj, A.S., Saint-Geniez, M., Maldonado, A.E. and D'Amore, P.A. (2006) Vascular endothelial growth factor localization in the adult. Am. J. Pathol. 168, 639-648
14. Robert, B., Zhao, X. and Abrahamson, D.R. (2000) Coexpression of neuropilin-1, Flk1, and VEGF(164) in developing and mature mouse kidney glomeruli. Am. J. Physiol. Renal Physiol. 279, F275-F282
15. Katavetin, P. (2008) VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 359, 205-206
16. Arkill, K.P., Qvortrup, K., Starborg, T., Mantell, J.M., Knupp, C., Michel, C.C., Harper, S.J., Salmon, A.H., Squire, J.M., Bates, D.O. et al. (2014) Resolution of the three dimensional structure of components of the glomerular filtration barrier. BMC Nephrol 15, 24
17. Salmon, A.H., Toma, I., Sipos, A., Muston, P.R., Harper, S.J., Bates, D.O., Neal, C.R. and Peti-Peterdi, J. (2007) Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space. Am. J. Physiol. Renal Physiol. 293, F1777-F1786
18. Salmon, A.H., Neal, C.R. and Harper, SJ. (2009) New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr. Opin. Nephrol. Hypertens. 18, 197-205
19. Thomas, S., Vanuystel, J., Gruden, G., Rodriguez, V., Burt, D., Gnudi, L., Hartley, B. and Viberti, G. (2000) Vascular endothelial growth factor receptors in human mesangium in vitro and in glomerular disease. J. Am. Soc. Nephrol. 11, 1236-1243
20. Sato, W., Tanabe, K., Kosugi, T., Hudkins, K., Lanaspa, M.A., Zhang, L., Campbell-Thompson, M., Li, Q., Long, D.A., Alpers, C.E. et al. (2011) Selective stimulation of VEGFR2 accelerates progressive renal disease. Am. J. Pathol. 179, 155-166
21. Ku, C.H., White, K.E., Dei, C.A., Hayward, A., Webster, Z., Bilous, R., Marshall, S., Viberti, G. and Gnudi, L. (2008) Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice. Diabetes 57, 2824-2833
22. Veron, D., Reidy, K.J., Bertuccio, C., Teichman, J., Villegas, G., Jimenez, J., Shen, W., Kopp, J.B., Thomas, D.B. and Tufro, A. (2010) Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease. Kidney Int. 77, 989-999
23. Sison, K., Eremina, V., Baelde, H., Min, W., Hirashima, M., Fantus, I.G. and Quaggin, S.E. (2010) Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. J. Am. Soc. Nephrol. 21, 1691-1701
24. Jin, J., Sison, K., Li, C., Tian, R., Wnuk, M., Sung, H.K., Jeansson, M., Zhang, C., Tucholska, M., Jones, N. et al. (2012) Soluble FLT1 binds lipid microdomains in podocytes to control cell morphology and glomerular barrier function. Cell 151, 384-99
25. Guan, F., Villegas, G., Teichman, J., Mundel, P. and Tufro, A. (2006) Autocrine VEGF-A system in podocytes regulates podocin and its interaction with CD2AP. Am. J. Physiol. Renal. Physiol. 291, F422-F428
26. Tuttle, K.R., Bakris, G.L., Bilous, R.W., Chiang, J.L., de Boer, I.H., Goldstein-Fuchs, J., Hirsch, I.B., Kalantar-Zadeh, K., Narva, A.S., Navaneethan, S.D. et al. (2014) Diabetic kidney disease: a report from an ADA consensus conference. Diabetes Care 37, 2864-2883
27. Nakagawa, T., Kosugi, T., Haneda, M., Rivard, C.J. and Long, D.A. (2009) Abnormal angiogenesis in diabetic nephropathy. Diabetes 58, 1471-1478
28. Hohenstein, B., Hausknecht, B., Boehmer, K., Riess, R., Brekken, R.A. and Hugo, C.P. (2006) Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man. Kidney Int. 69, 1654-1661
29. Wehner, H. and Nelischer, G. (1991) Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats. Virchows Arch. A Pathol. Anat. Histopathol. 419, 231-235
30. Guo, M., Ricardo, S.D., Deane, J.A., Shi, M., Cullen-McEwen, L. and Bertram, J.F. (2005) A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy. J. Anat. 207, 813-821
31. Cooper, M.E., Vranes, D., Youssef, S., Stacker, S.A., Cox, A.J., Rizkalla, B., Casley, D.J., Bach, L.A., Kelly, D.J., Gilbert, R.E. et al. (1999) Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes 48, 2229-2239
32. Veron, D., Bertuccio, C.A., Marlier, A., Reidy, K., Garcia, A.M., Jimenez, J., Velazquez, H., Kashgarian, M., Moeckel, G.W. and Tufro, A. (2011) Podocyte vascular endothelial growth factor (Vegf) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes. Diabetologia 54, 1227-1241
33. Sivaskandarajah, G.A., Jeansson, M., Maezawa, Y., Eremina, V., Baelde, H.J. and Quaggin, S.E. (2012) Vegfa protects the glomerular microvasculature in diabetes. Diabetes 61, 2958-2966
34. Foster, R.R., Armstrong, L., Baker, S., Wong, D.W., Wylie, E.C., Ramnath, R., Jenkins, R., Singh, A., Steadman, R., Welsh, G.I. et al. (2013) Glycosaminoglycan regulation by VEGFA and VEGFC of the glomerular microvascular endothelial cell glycocalyx in vitro. Am. J. Pathol. 183, 604-616
35. De Vriese, A.S., Tilton, R.G., Elger, M., Stephan, C.C., Kriz, W. and Lameire, N.H. (2001) Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J. Am. Soc. Nephrol. 12, 993-1000
36. Flyvbjerg, A., Dagnaes-Hansen, F., De Vriese, A.S., Schrijvers, B.F., Tilton, R.G. and Rasch, R. (2002) Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51, 3090-3094
37. Sung, S.H., Ziyadeh, F.N., Wang, A., Pyagay, P.E., Kanwar, Y.S. and Chen, S. (2006) Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J. Am. Soc. Nephrol. 17, 3093-3104
38. Kendall, R.L. and Thomas, K.A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 10705-10709
39. Predescu, D., Predescu, S., Shimizu, J., Miyawaki-Shimizu, K. and Malik, A.B. (2005) Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L371-L381
40. Ziche, M., Morbidelli, L., Choudhuri, R., Zhang, H.T., Donnini, S., Granger, H.J. and Bicknell, R. (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J. Clin. Invest. 99, 2625-2634
41. Nakagawa, T. (2007) Uncoupling of the VEGF-endothelial nitric oxide axis in diabetic nephropathy: an explanation for the paradoxical effects of VEGF in renal disease. Am. J. Physiol. Renal. Physiol. 292, F1665-F1672
42. Bussolati, B., Dunk, C., Grohman, M., Kontos, C.D., Mason, J. and Ahmed, A. (2001) Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am. J. Pathol. 159, 993-1008
43. Yuen, D.A., Stead, B.E., Zhang, Y., White, K.E., Kabir, M.G., Thai, K., Advani, S.L., Connelly, K.A., Takano, T., Zhu, L. et al. (2012) eNOS deficiency predisposes podocytes to injury in diabetes. J. Am. Soc. Nephrol. 23, 1810-1823
44. Baelde, H.J., Eikmans, M., Lappin, D.W., Doran, P.P., Hohenadel, D., Brinkkoetter, P.T., van der Woude, F.J., Waldherr, R., Rabelink, T.J., de Heer, E. et al. (2007) Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. Kidney Int. 71, 637-645
45. Keir, L. and Coward, R.J. (2011) Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy. Pediatr. Nephrol. 26, 523-533
46. Zheng, X.L. and Sadler, JE (2008) Pathogenesis of thrombotic microangiopathies. Annu. Rev. Pathol. 3, 249-277
47. Eremina, V., Jefferson, J.A., Kowalewska, J., Hochster, H., Haas, M., Weisstuch, J., Richardson, C., Kopp, J.B., Kabir, M.G., Backx, P.H. et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 358, 1129-1136
48. Bollee, G., Patey, N., Cazajous, G., Robert, C., Goujon, J.M., Fakhouri, F., Bruneval, P., Noel, L.H. and Knebelmann, B. (2009) Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib. Nephrol. Dial. Transplant. 24, 682-685
49. Hohenstein, B., Braun, A., Amann, K.U., Johnson, R.J. and Hugo, C.P. (2008) A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Nephrol. Dial. Transplant. 23, 1144-1156
50. Kim, Y.G., Suga, S.I., Kang, D.H., Jefferson, J.A., Mazzali, M., Gordon, K.L., Matsui, K., Breiteneder-Geleff, S., Shankland, S.J., Hughes, J. et al. (2000) Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int. 58, 2390-2399
51. Couser, W.G. (1999) Glomerulonephritis. Lancet 353, 1509-1515
52. Shimizu, A., Kitamura, H., Masuda, Y., Ishizaki, M., Sugisaki, Y. and Yamanaka, N. (1997) Rare glomerular capillary regeneration and subsequent capillary regression with endothelial cell apoptosis in progressive glomerulonephritis. Am. J. Pathol. 151, 1231-1239
53. Shimizu, A., Masuda, Y., Mori, T., Kitamura, H., Ishizaki, M., Sugisaki, Y. and Fukuda, Y. (2004) Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J. Am. Soc. Nephrol. 15, 2655-2665
54. Mesnard, L., Cathelin, D., Vandermeersch, S., Rafat, C., Luque, Y., Sohier, J., Nochy, D., Garcon, L., Callard, P., Jouanneau, C. et al. (2014) Genetic background-dependent thrombotic microangiopathy is related to vascular endothelial growth factor receptor 2 signaling during anti-glomerular basement membrane glomerulonephritis in mice. Am. J. Pathol. 184, 2438-2449
55. Young, B.C., Levine, R.J. and Karumanchi, S.A. (2010) Pathogenesis of preeclampsia. Annu. Rev. Pathol. 5, 173-192
56. Davison, J.M., Homuth, V., Jeyabalan, A., Conrad, K.P., Karumanchi, S.A., Quaggin, S., Dechend, R. and Luft, F.C. (2004) New aspects in the pathophysiology of preeclampsia. J. Am. Soc. Nephrol. 15, 2440-2448
57. Maynard, S.E., Min, J.Y., Merchan, J., Lim, K.H., Li, J., Mondal, S., Libermann, T.A., Morgan, J.P., Sellke, F.W., Stillman, I.E. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658.
58. Verlohren, S., Stepan, H. and Dechend, R. (2012) Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin. Sci. 122, 43-52
59. Levine, R.J., Maynard, S.E., Qian, C., Lim, K.H., England, L.J., Yu, K.F., Schisterman, E.F., Thadhani, R., Sachs, B.P., Epstein, F.H. et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683
60. Baumann, M.U., Bersinger, N.A., Mohaupt, M.G., Raio, L., Gerber, S. and Surbek, D.V. (2008) First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am. J. Obstet. Gynecol. 199, 266.e1-266.e6
61. Fan, X., Rai, A., Kambham, N., Sung, J.F., Singh, N., Petitt, M., Dhal, S., Agrawal, R., Sutton, R.E., Druzin, M.L. et al. (2014) Endometrial VEGF induces placental sFLT1 and leads to pregnancy complications. J. Clin. Invest. 124, 4941-4952
62. Sugimoto, H., Hamano, Y., Charytan, D., Cosgrove, D., Kieran, M., Sudhakar, A. and Kalluri, R. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J. Biol. Chem. 278, 12605-12608
63. Li, Z., Zhang, Y., Ying Ma, J., Kapoun, A.M., Shao, Q., Kerr, I., Lam, A., O'Young, G., Sannajust, F., Stathis, P. et al. (2007) Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension 50, 686-692
64. Eremina, V., Sood, M., Haigh, J., Nagy, A., Lajoie, G., Ferrara, N., Gerber, H.P., Kikkawa, Y., Miner, J.H. and Quaggin, S.E. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J. Clin. Invest. 111, 707-716
65. Bevan, H.S., van den Akker, N.M., Qiu, Y., Polman, J.A., Foster, R.R., Yem, J., Nishikawa, A., Satchell, S.C., Harper, S.J., Gittenberger-de Groot, A.C. et al. (2008) The alternatively spliced anti-angiogenic family of VEGF isoforms VEGFxxxb in human kidney development. Nephron Physiol. 110, 57-67
66. Qiu, Y., Ferguson, J., Oltean, S., Neal, C.R., Kaura, A., Bevan, H., Wood, E., Sage, L.M., Lanati, S., Nowak, D.G. et al. (2010) Overexpression of VEGF165b in podocytes reduces glomerular permeability. J. Am. Soc. Nephrol. 21, 1498-1509
67. Oltean, S., Qiu, Y., Ferguson, J.K., Stevens, M., Neal, C., Russell, A., Kaura, A., Arkill, K.P., Harris, K., Symonds, C. et al. (2015) Vascular endothelial growth factor-A165b Is protective and restores endothelial glycocalyx in diabetic nephropathy. J. Am. Soc. Nephrol. 26, 1889-1904
68. Huggenberger, R., Ullmann, S., Proulx, S.T., Pytowski, B., Alitalo, K. and Detmar, M. (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J. Exp. Med. 207, 2255-2269
69. Makinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E.C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D. et al. (2001) Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J. 20, 4762-4773
70. Hamada, K., Oike, Y., Takakura, N., Ito, Y., Jussila, L., Dumont, D.J., Alitalo, K. and Suda, T. (2000) VEGF-C signaling pathways through VEGFR-2 and VEGFR-3 in vasculoangiogenesis and hematopoiesis. Blood 96, 3793-3800
71. Foster, R.R., Satchell, S.C., Seckley, J., Emmett, M.S., Joory, K., Xing, C.Y., Saleem, M.A., Mathieson, P.W., Bates, D.O. and Harper, S.J. (2006) VEGF-C promotes survival in podocytes. Am. J. Physiol. Renal Physiol. 291, F196-F207
72. Muller-Deile, J., Worthmann, K., Saleem, M., Tossidou, I., Haller, H. and Schiffer, M. (2009) The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am. J. Physiol. Renal Physiol. 297, F1656-F1667
73. Foster, R.R., Slater, S.C., Seckley, J., Kerjaschki, D., Bates, D.O., Mathieson, P.W. and Satchell, S.C. (2008) Vascular endothelial growth factor-C, a potential paracrine regulator of glomerular permeability, increases glomerular endothelial cell monolayer integrity and intracellular calcium. Am. J. Pathol. 173, 938-948
74. Woolf, A.S., Gnudi, L. and Long, D.A. (2009) Roles of angiopoietins in kidney development and disease. J. Am. Soc. Nephrol. 20, 239-244
75. Kim, K.T., Choi, H.H., Steinmetz, M.O., Maco, B., Kammerer, R.A., Ahn, S.Y., Kim, H.Z., Lee, G.M. and Koh, G.Y. (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. TJ. Biol. Chem. 280, 20126-20131
76. Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N. and Yancopoulos, G.D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180
77. Jeansson, M., Gawlik, A., Anderson, G., Li, C., Kerjaschki, D., Henkelman, M. and Quaggin, S.E. (2011) Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J. Clin. Invest. 121, 2278-2289
78. Gavard, J., Patel, V. and Gutkind, J.S. (2008) Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev. Cell 14, 25-36
79. Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T.N., Yancopoulos, G.D. and McDonald, D.M. (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286, 2511-2514
80. Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T.H., Papadopoulos, N. et al. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60
81. Hakanpaa, L., Sipila, T., Leppanen, V.M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K. and Saharinen, P. (2015) Endothelial destabilization by angiopoietin-2 via integrin beta1 activation. Nat. Commun. 6, 1-12
82. Yuan, H.T., Suri, C., Yancopoulos, G.D. and Woolf, A.S. (1999) Expression of angiopoietin-1, angiopoietin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation. J. Am. Soc. Nephrol. 10, 1722-1736
83. Satchell, S.C., Harper, S.J., Tooke, J.E., Kerjaschki, D., Saleem, M.A. and Mathieson, P.W. (2002) Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J. Am. Soc. Nephrol. 13, 544-550
84. Yuan, H.T., Suri, C., Landon, D.N., Yancopoulos, G.D. and Woolf, A.S. (2000) Angiopoietin-2 is a site-specific factor in differentiation of mouse renal vasculature. J. Am. Soc. Nephrol. 11, 1055-1066
85. Long, D.A., Woolf, A.S., Suda, T. and Yuan, H.T. (2001) Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J. Am. Soc. Nephrol. 12, 2721-2731
86. Dessapt-Baradez, C., Woolf, A.S., White, K.E., Pan, J., Huang, J.L., Hayward, A.A., Price, K.L., Kolatsi-Joannou, M., Locatelli, M., Diennet, M. et al. (2014) Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease. J. Am. Soc. Nephrol. 25, 33-42
87. Rizkalla, B., Forbes, J.M., Cao, Z., Boner, G. and Cooper, M.E. (2005) Temporal renal expression of angiogenic growth factors and their receptors in experimental diabetes: role of the renin-angiotensin system. J. Hypertens. 23, 153-164
88. Yao, D., Taguchi, T., Matsumura, T., Pestell, R., Edelstein, D., Giardino, I., Suske, G., Rabbani, N., Thornalley, P.J., Sarthy, V.P. et al. (2007) High glucose increases angiopoietin-2 transcription in microvascular endothelial cells through methylglyoxal modification of mSin3A. J. Biol. Chem. 282, 31038-31045
89. Lim, H.S., Blann, A.D., Chong, A.Y., Freestone, B. and Lip, G.Y. (2004) Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention. Diabetes Care 27, 2918-2924
90. Davis, B., Dei Cas, A., Long, D.A., White, K.E., Hayward, A., Ku, C.H., Woolf, A.S., Bilous, R., Viberti, G. and Gnudi, L. (2007) Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia. J. Am. Soc. Nephrol. 18, 2320-2329
91. Babaei, S., Teichert-Kuliszewska, K., Zhang, Q., Jones, N., Dumont, D.J. and Stewart, D.J. (2003) Angiogenic actions of angiopoietin-1 require endothelium-derived nitric oxide. Am. J. Pathol. 162, 1927-1936
92. Zhu, J., Sun, N., Aoudjit, L., Li, H., Kawachi, H., Lemay, S. and Takano, T. (2008) Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes. Kidney Int. 73, 556-566
93. Lee, S., Kim, W., Moon, S.O., Sung, M.J., Kim, D.H., Kang, K.P., Jang, K.Y., Lee, S.Y., Park, B.H., Koh, G.Y. et al. (2007) Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes. Nephrol. Dial. Transplant. 22, 396-408
94. Shen, J., Frye, M., Lee, B.L., Reinardy, J.L., McClung, J.M., Ding, K., Kojima, M., Xia, H., Seidel, C., Lima e Silva, R. et al. (2014) Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature. J. Clin. Invest. 124, 4564-4576
95. Yuan, H.T., Tipping, P.G., Li, X.Z., Long, D.A. and Woolf, A.S. (2002) Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int. 61, 2078-2089
96. Lu, Y.H., Deng, A.G., Li, N., Song, M.N., Yang, X. and Liu, J.S. (2006) Changes in angiopoietin expression in glomeruli involved in glomerulosclerosis in rats with daunorubicin-induced nephrosis. Acta Pharmacol. Sin. 27, 579-587
97. Campean, V., Karpe, B., Haas, C., Atalla, A., Peters, H., Rupprecht, H., Liebner, S., Acker, T., Plate, K. and Amann, K. (2008) Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis. Am. J. Physiol. Renal Physiol. 294, F1174-F1184
98. Long, D.A., Norman, J.T. and Fine, L.G. (2012) Restoring the renal microvasculature to treat chronic kidney disease. Nat. Rev. Nephrol. 8, 244-250
99. Dimke, H., Sparks, M.A., Thomson, B.R., Frische, S., Coffman, T.M. and Quaggin, S.E. (2015) Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney. J. Am. Soc. Nephrol. 26, 1027-1038
100. Huang, J.L., Woolf, A.S., Kolatsi-Joannou, M., Baluk, P., Sandford, R.N., Peters, D.J., McDonald, D.M., Price, K.L., Winyard, P.J. and Long, D.A. (2015) Vascular endothelial growth factor C for polycystic kidney diseases. J. Am. Soc. Nephrol., in the press
101. Kida, Y., Tchao, B.N. and Yamaguchi, I. (2014) Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease. Pediatr. Nephrol. 29, 333-342
102. Tanaka, T. and Nangaku, M. (2013) Angiogenesis and hypoxia in the kidney. Nat. Rev. Nephrol. 9, 211-222
103. Kang, D.H., Hughes, J., Mazzali, M., Schreiner, G.F. and Johnson, R.J. (2001) Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J. Am. Soc. Nephrol. 12, 1448-1457
104. Long, D.A., Price, K.L., Ioffe, E., Gannon, C.M., Gnudi, L., White, K.E., Yancopoulos, G.D., Rudge, J.S. and Woolf, A.S. (2008) Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Kidney Int. 74, 300-309